ARACELIS LU BREA: Open Payments
NPI 1164723318 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 14 payments from 6 companies in 2025. Trend: 2023 $133 · 2024 $104 · 2025 $965
Travel & lodging: $638Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $845 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: SPRAVATO, REXULTI, COBENFY, CAPLYTA, FANAPT, Jornay PM.
Industry payments across MS — which companies pay providers there.
